Epidemiology and burden of malaria in pregnancy.

We reviewed evidence of the clinical implications and burden of malaria in pregnancy. Most studies come from sub-Saharan Africa, where approximately 25 million pregnant women are at risk of Plasmodium falciparum infection every year, and one in four women have evidence of placental infection at the...

Full description

Bibliographic Details
Main Authors: Desai, M, ter Kuile, F, Nosten, F, Mcgready, R, Asamoa, K, Brabin, B, Newman, R
Format: Journal article
Language:English
Published: 2007
_version_ 1826272497574608896
author Desai, M
ter Kuile, F
Nosten, F
Mcgready, R
Asamoa, K
Brabin, B
Newman, R
author_facet Desai, M
ter Kuile, F
Nosten, F
Mcgready, R
Asamoa, K
Brabin, B
Newman, R
author_sort Desai, M
collection OXFORD
description We reviewed evidence of the clinical implications and burden of malaria in pregnancy. Most studies come from sub-Saharan Africa, where approximately 25 million pregnant women are at risk of Plasmodium falciparum infection every year, and one in four women have evidence of placental infection at the time of delivery. P falciparum infections during pregnancy in Africa rarely result in fever and therefore remain undetected and untreated. Meta-analyses of intervention trials suggest that successful prevention of these infections reduces the risk of severe maternal anaemia by 38%, low birthweight by 43%, and perinatal mortality by 27% among paucigravidae. Low birthweight associated with malaria in pregnancy is estimated to result in 100,000 infant deaths in Africa each year. Although paucigravidae are most affected by malaria, the consequences for infants born to multigravid women in Africa may be greater than previously appreciated. This is because HIV increases the risk of malaria and its adverse effects, particularly in multigravidae, and recent observational studies show that placental infection almost doubles the risk of malaria infection and morbidity in infants born to multigravidae. Outside Africa, malaria infection rates in pregnant women are much lower but are more likely to cause severe disease, preterm births, and fetal loss. Plasmodium vivax is common in Asia and the Americas and, unlike P falciparum, does not cytoadhere in the placenta, yet, is associated with maternal anaemia and low birthweight. The effect of infection in the first trimester, and the longer term effects of malaria beyond infancy, are largely unknown and may be substantial. Better estimates are also needed of the effects of malaria in pregnancy outside Africa, and on maternal morbidity and mortality in Africa. Global risk maps will allow better estimation of potential impact of successful control of malaria in pregnancy.
first_indexed 2024-03-06T22:13:30Z
format Journal article
id oxford-uuid:529dd1fa-4893-4b1d-be27-02a251de12f3
institution University of Oxford
language English
last_indexed 2024-03-06T22:13:30Z
publishDate 2007
record_format dspace
spelling oxford-uuid:529dd1fa-4893-4b1d-be27-02a251de12f32022-03-26T16:26:34ZEpidemiology and burden of malaria in pregnancy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:529dd1fa-4893-4b1d-be27-02a251de12f3EnglishSymplectic Elements at Oxford2007Desai, Mter Kuile, FNosten, FMcgready, RAsamoa, KBrabin, BNewman, RWe reviewed evidence of the clinical implications and burden of malaria in pregnancy. Most studies come from sub-Saharan Africa, where approximately 25 million pregnant women are at risk of Plasmodium falciparum infection every year, and one in four women have evidence of placental infection at the time of delivery. P falciparum infections during pregnancy in Africa rarely result in fever and therefore remain undetected and untreated. Meta-analyses of intervention trials suggest that successful prevention of these infections reduces the risk of severe maternal anaemia by 38%, low birthweight by 43%, and perinatal mortality by 27% among paucigravidae. Low birthweight associated with malaria in pregnancy is estimated to result in 100,000 infant deaths in Africa each year. Although paucigravidae are most affected by malaria, the consequences for infants born to multigravid women in Africa may be greater than previously appreciated. This is because HIV increases the risk of malaria and its adverse effects, particularly in multigravidae, and recent observational studies show that placental infection almost doubles the risk of malaria infection and morbidity in infants born to multigravidae. Outside Africa, malaria infection rates in pregnant women are much lower but are more likely to cause severe disease, preterm births, and fetal loss. Plasmodium vivax is common in Asia and the Americas and, unlike P falciparum, does not cytoadhere in the placenta, yet, is associated with maternal anaemia and low birthweight. The effect of infection in the first trimester, and the longer term effects of malaria beyond infancy, are largely unknown and may be substantial. Better estimates are also needed of the effects of malaria in pregnancy outside Africa, and on maternal morbidity and mortality in Africa. Global risk maps will allow better estimation of potential impact of successful control of malaria in pregnancy.
spellingShingle Desai, M
ter Kuile, F
Nosten, F
Mcgready, R
Asamoa, K
Brabin, B
Newman, R
Epidemiology and burden of malaria in pregnancy.
title Epidemiology and burden of malaria in pregnancy.
title_full Epidemiology and burden of malaria in pregnancy.
title_fullStr Epidemiology and burden of malaria in pregnancy.
title_full_unstemmed Epidemiology and burden of malaria in pregnancy.
title_short Epidemiology and burden of malaria in pregnancy.
title_sort epidemiology and burden of malaria in pregnancy
work_keys_str_mv AT desaim epidemiologyandburdenofmalariainpregnancy
AT terkuilef epidemiologyandburdenofmalariainpregnancy
AT nostenf epidemiologyandburdenofmalariainpregnancy
AT mcgreadyr epidemiologyandburdenofmalariainpregnancy
AT asamoak epidemiologyandburdenofmalariainpregnancy
AT brabinb epidemiologyandburdenofmalariainpregnancy
AT newmanr epidemiologyandburdenofmalariainpregnancy